Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein as Treatment for Gout Flare

Key Points

• To explore the effectiveness of etanercept as a treatment for gout flares in patients resistant to conventional therapies.
• Analyzed the potential off-label use of etanercept.
• Considered patients experiencing severe side effects from standard treatments.
• Evaluated the response in patients with contraindications to other therapies.
• Etanercept may provide symptom relief for gout flares.
• Patients showed variation in response to treatment.
• Some reported improved outcomes compared to traditional therapy.

Abstract